Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats

Hypertension Research

Volumn 36, Issue 4, 2013, Pages 349-355

  Bertera, Facundo Martín ^a   Del Mauro, Julieta Sofía ^a   Lovera, Valeria ^a   Chiappetta, Diego ^a   Héctor Polizio, Ariel ^a   Alberto Taira, Carlos ^a   Höcht, Christian ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

blockers; blood pressure variability; calcium channel blockers; sinoaortic denervation

Indexed keywords

ATENOLOL; CARVEDILOL; NEBIVOLOL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS DENERVATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; DRUG MEGADOSE; HEART DENERVATION; LOW DRUG DOSE; LOW FREQUENCY NOISE; MALE; NONHUMAN; RAT; SPECTROSCOPY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARTERIAL PRESSURE; ATENOLOL; BENZOPYRANS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARBAZOLES; DENERVATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; HEART RATE; MALE; PROPANOLAMINES; RATS; RATS, WISTAR; SINOATRIAL NODE; VERAPAMIL;

EID: 84877107021     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.209     Document Type: Article

References (39)

1. Grassi G, Bombelli M, Brambilla G, Trevano FQ, Delloro R, Mancia G. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep 2012; 14: 333-338.
2. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens 2005; 23 (suppl 1): S19-S25.
3. Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan NT, Malan L. Blood pressure variability is significantly associated with ECG left ventricular mass in normotensive Africans: the SABPA Study. Hypertens Res 2011; 34: 1127-1134.
4. Ushigome E, Fukui M, Hamaguchi M, Senmaru T, Sakabe K, Tanaka M, Yamazaki M, Hasegawa G, Nakamura N. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res 2011; 34: 1271-1275.
5. Schillaci G, Pucci G, Parati G. Blood pressure variability: an additional target for antihypertensive treatment? Hypertension 2001; 58: 133-135.
6. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375: 906-915.
7. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Poulter NR, Sever PS. ASCOT-BPLA and MRC Trial Investigators. Effects of beta-blockers and calciumchannel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9: 469-480.
8. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012; 30: 1241-1251.
9. Hocht C, Bertera FM, Mayer MA, Taira CA. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Expert Opin Drug Metab Toxicol 2010; 6: 199-211.
10. Webb AJ, Fischer U, Rothwell PM. Effects of b-blocker selectivity on blood pressure variability and stroke: a systematic review. Neurology 2011; 77: 731-737.
11. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 2001; 28: 709-715.
12. Wang J, Shen FM, Wang MW, Su DF. Effects of nine antihypertensive drugs on blood pressure variability in sinoaortic-denervated rats. Acta Pharmacol Sin 2006; 27: 1013-1017.
13. Wang J, Shen FM, Zhang XF, Wang MW, Su DF. Functional arterial baroreflex attenuates the effects of antihypertensive drugs in conscious rats. J Pharmacol Sci 2006; 100: 271-277.
14. Miao CY, Xie HH, Wang JJ, Su DF. Candesartan inhibits sinoaortic denervation-induced cardiovascular hypertrophy in rats. Acta Pharmacol Sin 2002; 23: 713-720.
15. Zhang LC, Li ZZ, Yu YS, Wang ZB, Wei X, Su DF, Li L. Angiotensin- converting enzyme and Angiotensin-converting enzyme 2 are involved in sinoaortic denervation-induced cardiovascular hypertrophy in rats. Biol Pharm Bull 2011; 34: 1398-1403.
16. Krieger EM. Neurogenic hypertension in the rats. Circulation Res 1964; 15: 511-521.
17. Opezzo JA, Ho?cht C, Taira CA. Pharmacokinetic profile of methyldopa in the brain of sinaortic-denervated rats. Pharmacol Res 2003; 48: 61-67.
18. Opezzo JA, Ho?cht C, Taira CA, Bramuglia GF. Study of the evolution of blood and striatal levels of methyldopa: a microdialysis study in sinaortic denervated rats. Pharmacol Res 2000; 41: 455-459.
19. Bertera FM, Del Mauro JS, Polizio AH, Chiappetta D, Taira CA, Hocht C. Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol 2012; 385: 833-843.
20. Bertera FM, Del Mauro JS, Chiappetta D, Polizio AH, Buontempo F, Taira CA, Hocht C. Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability. Naunyn Schmiedebergs Arch Pharmacol 2012; 385: 325-335.
21. Bertera FM, Mayer MA, Opezzo JA, Taira CA, Hocht C. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension. J Pharmacol Toxicol Methods 2008; 57: 212-219.
22. Di Verniero CA, Bertera F, Buontempo F, Bernabeu E, Chiappetta D, Mayer MA, Bramuglia GF, Taira CA, Hocht C. Enantioselective pharmacokinetic- pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension. J Pharm Pharmacol 2010; 62: 890-900.
23. Pladys P, Lahaie I, Cambonie G, Thibault G, Lê NL, Abran D, Nuyt AM. Role of brain and peripheral angiotensin II in hypertension and altered arterial baroreflex programmed during fetal life in rat. Pediatr Res 2004; 55: 1042-1049.
24. Souza HC, Martins-Pinge MC, Dias da Silva VJ, Borghi-Silva A, Gastaldi AC, Blanco JH, Tezini GC. Heart rate and arterial pressure variability in the experimental renovascular hypertension model in rats. Auton Neurosci 2008; 139: 38-45.
25. Irigoyen MC, Cestari IA, Moreira ED, Oshiro MS, Krieger EM. Measurements of renal sympathetic nerve activity in conscious sinoaortic denervated rats. Braz J Med Biol Res 1988; 21: 869-872.
26. Van Vliet BN, Chafe LL. Reduction of blood pressure variability by amlodipine in baroreceptor denervated rats. Clin Exp Hypertens 2000; 22: 645-661.
27. Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, Ghodsi N, Lucet B, Azoui R, Laurent S. Aortic distensibility and structural changes in sinoaorticdenervated rats. Hypertension 1995; 26: 337-340.
28. Kuroedov A, Cosentino F, Luscher TF. Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol. Cardiovasc Drug Rev 2004; 22: 155-168.
29. Meier K, Gorbey S, Lemmer B. Effects of nebivolol and metoprolol on nitric oxide urinary excretion, on expression of eNOS and on blood pressure in SH-rats. Naunyn Schmiedebergs Arch Pharmacol 2004; 369 (Suppl 1): R42.
30. Rocha ML, Bendhack LM. Spontaneous oscillatory contractions in aortas of rats with arterial pressure lability caused by sinoaortic denervation. Clin Exp Pharmacol Physiol 2007; 34: 708-713.
31. Zepeda RJ, Castillo R, Rodrigo R, Prieto JC, Aramburu I, Brugere S, Galdames K, Noriega V, Miranda HF. Effect of Carvedilol and Nebivolol on Oxidative Stress-related Parameters and Endothelial Function in Patients with Essential Hypertension. Basic Clin Pharmacol Toxicol 2012; 111: 309-316.
32. Virdis A, Ghiadoni L, Taddei S. Effects of antihypertensive treatment on endothelial function. Curr Hypertens Rep 2011; 13: 276-281.
33. Stauss HM. Identification of blood pressure control mechanisms by power spectral analysis. Clin Exp Pharmacol Physiol 2007; 34: 362-388.
34. Janssen BJ, Oosting J, Slaaf DW, Persson PB, Struijker-Boudier HA. Hemodynamic basis of oscillations in systemic arterial pressure in conscious rats. Am J Physiol 1995; 269: H62-H71.
35. Fazan Jr R, Huber DA, Silva CA, Dias da Silva VJ, Salgado MC, Salgado HC. Sildenafil acts on the central nervous system increasing sympathetic activity. J Appl Physiol 2008; 104: 1683-1689.
36. Just A, Faulhaber J, Ehmke H. Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 2000; 279: R2214-R2221.
37. Bertera F, Di Verniero CA, Mayer MA, Chiappetta D, Buontempo F, Polizio AH, Taira CA, Hocht C. Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats. Xenobiotica 2012; 42: 206-219.
38. Chiladakis JA, Georgiopoulou E, Alexopoulos D. Autonomic effects of nebivolol versus atenolol in healthy subjects. Cardiovasc Drugs Ther 2004; 18: 469-473.
39. Sacco G, Evangelista S, Criscuoli M, Goso C, Bigioni M, Binaschi M, Manzini S, Maggi CA. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats. Eur J Pharmacol 2005; 511: 167-174.